Try our Advanced Search for more refined results
March 13, 2009
Genzyme Corporation v. Impax Laboratories, Inc.
Case Number:
1:09-cv-00653
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
September 05, 2012
Genzyme, Impax Bury Hatchet Over Kidney Disease Drugs
Impax Laboratories Inc. on Tuesday settled patent infringement claims brought by Sanofi-Aventis SA subsidiary Genzyme Corp. over plans to make generic versions of two Genzyme kidney disease treatments, reaching a deal that will give Impax licensing rights in 2014.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login